TransMedics Common Stock from 2010 to 2025

TMDX Stock

USD 73.00 4.12 5.34%

TransMedics Common Stock yearly trend continues to be fairly stable with very little volatility. Common Stock will likely drop to about 375.9 M in 2025. During the period from 2010 to 2025, TransMedics Common Stock regression line of annual values had r-squared of 0.76 and arithmetic mean of 261,787,540. View All Fundamentals

Common Stock

First Reported

2018-06-30

Previous Quarter

669.4 M

Current Value

685.3 M

Quarterly Volatility

201.6 M

Covid

Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 13 M, Selling General Administrative of 144.4 M or Research Development of 76.4 M, as well as many indicators such as Price To Sales Ratio of 11.6, Dividend Yield of 0.0 or PTB Ratio of 17.68. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.

Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Common Stock Growth Pattern

Below is the plot of the Common Stock of TransMedics Group over the last few years. It is TransMedics' Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.

Common Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Common Stock

Timeline

TransMedics Common Stock Regression Statistics

	Arithmetic Mean	261,787,540
	Geometric Mean	710,984
	Coefficient Of Variation	110.08
	Mean Deviation	261,786,540
	Median	331,212,000
	Standard Deviation	288,177,045
	Sample Variance	83046T
	Range	737.3M
	R-Value	0.87
	Mean Square Error	21063.5T
	R-Squared	0.76
	Slope	52,881,685
	Total Sum of Squares	1245690.1T

TransMedics Common Stock History

	2025	375.9 M
	2024	737.3 M
	2023	641.1 M
	2022	666.3 M
	2021	510.5 M
	2020	502.2 M
	2019	424.1 M

Other Fundumenentals of TransMedics Group

	Common Stock Shares Outstanding
	Common Stock Total Equity

TransMedics Common Stock component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.74	0.82	-0.69	0.92	0.99	-0.45	0.97	1.0	0.67	0.91	1.0	0.98	0.76	0.61	0.8	0.97	-0.78	1.0	-0.15	-0.64	0.83	-0.78
Total Stockholder Equity	0.74		0.94	-0.76	0.58	0.66	-0.17	0.62	0.77	0.95	0.86	0.74	0.61	0.33	0.94	0.5	0.87	-0.48	0.79	0.4	-0.92	0.91	-0.48
Net Tangible Assets	0.82	0.94		-0.74	0.65	0.74	-0.14	0.71	0.85	0.88	0.9	0.82	0.7	0.41	0.81	0.57	0.89	-0.55	0.87	0.18	-0.93	0.94	-0.55
Retained Earnings	-0.69	-0.76	-0.74		-0.66	-0.62	0.04	-0.62	-0.72	-0.81	-0.79	-0.68	-0.57	-0.32	-0.79	-0.4	-0.77	0.4	-0.72	-0.28	0.79	-0.8	0.4
Accounts Payable	0.92	0.58	0.65	-0.66		0.94	-0.41	0.92	0.9	0.55	0.8	0.91	0.93	0.83	0.54	0.78	0.88	-0.76	0.89	-0.09	-0.54	0.66	-0.76
Long Term Debt	0.99	0.66	0.74	-0.62	0.94		-0.48	0.98	0.98	0.6	0.85	0.98	1.0	0.85	0.56	0.81	0.94	-0.79	0.97	-0.18	-0.56	0.75	-0.79
Short Term Investments	-0.45	-0.17	-0.14	0.04	-0.41	-0.48		-0.51	-0.42	-0.1	-0.44	-0.51	-0.5	-0.26	-0.05	-0.38	-0.37	0.36	-0.43	0.51	-0.11	-0.25	0.36
Total Liab	0.97	0.62	0.71	-0.62	0.92	0.98	-0.51		0.95	0.57	0.84	0.96	0.98	0.83	0.52	0.8	0.92	-0.78	0.95	-0.2	-0.53	0.73	-0.78
Total Current Assets	1.0	0.77	0.85	-0.72	0.9	0.98	-0.42	0.95		0.7	0.93	0.99	0.96	0.73	0.64	0.79	0.98	-0.77	1.0	-0.13	-0.68	0.86	-0.77
Common Stock	0.67	0.95	0.88	-0.81	0.55	0.6	-0.1	0.57	0.7		0.81	0.67	0.54	0.28	0.96	0.45	0.81	-0.3	0.72	0.44	-0.93	0.92	-0.3
Property Plant Equipment	0.91	0.86	0.9	-0.79	0.8	0.85	-0.44	0.84	0.93	0.81		0.92	0.82	0.47	0.73	0.68	0.94	-0.66	0.93	-0.03	-0.77	0.93	-0.66
Net Receivables	1.0	0.74	0.82	-0.68	0.91	0.98	-0.51	0.96	0.99	0.67	0.92		0.97	0.74	0.61	0.8	0.97	-0.78	0.99	-0.17	-0.63	0.83	-0.78
Current Deferred Revenue	0.98	0.61	0.7	-0.57	0.93	1.0	-0.5	0.98	0.96	0.54	0.82	0.97		0.87	0.5	0.82	0.92	-0.8	0.95	-0.22	-0.5	0.71	-0.8
Net Debt	0.76	0.33	0.41	-0.32	0.83	0.85	-0.26	0.83	0.73	0.28	0.47	0.74	0.87		0.32	0.7	0.7	-0.69	0.72	-0.09	-0.28	0.37	-0.69
Long Term Debt Total	0.61	0.94	0.81	-0.79	0.54	0.56	-0.05	0.52	0.64	0.96	0.73	0.61	0.5	0.32		0.43	0.78	-0.34	0.66	0.61	-0.89	0.81	-0.34
Capital Surpluse	0.8	0.5	0.57	-0.4	0.78	0.81	-0.38	0.8	0.79	0.45	0.68	0.8	0.82	0.7	0.43		0.75	-0.85	0.79	-0.16	-0.42	0.62	-0.85
Net Invested Capital	0.97	0.87	0.89	-0.77	0.88	0.94	-0.37	0.92	0.98	0.81	0.94	0.97	0.92	0.7	0.78	0.75		-0.73	0.98	0.07	-0.77	0.89	-0.73
Short Long Term Debt	-0.78	-0.48	-0.55	0.4	-0.76	-0.79	0.36	-0.78	-0.77	-0.3	-0.66	-0.78	-0.8	-0.69	-0.34	-0.85	-0.73		-0.77	0.13	0.33	-0.47	1.0
Net Working Capital	1.0	0.79	0.87	-0.72	0.89	0.97	-0.43	0.95	1.0	0.72	0.93	0.99	0.95	0.72	0.66	0.79	0.98	-0.77		-0.11	-0.7	0.87	-0.77
Short Term Debt	-0.15	0.4	0.18	-0.28	-0.09	-0.18	0.51	-0.2	-0.13	0.44	-0.03	-0.17	-0.22	-0.09	0.61	-0.16	0.07	0.13	-0.11		-0.44	0.08	0.13
Deferred Long Term Liab	-0.64	-0.92	-0.93	0.79	-0.54	-0.56	-0.11	-0.53	-0.68	-0.93	-0.77	-0.63	-0.5	-0.28	-0.89	-0.42	-0.77	0.33	-0.7	-0.44		-0.89	0.33
Capital Stock	0.83	0.91	0.94	-0.8	0.66	0.75	-0.25	0.73	0.86	0.92	0.93	0.83	0.71	0.37	0.81	0.62	0.89	-0.47	0.87	0.08	-0.89		-0.47
Intangible Assets	-0.78	-0.48	-0.55	0.4	-0.76	-0.79	0.36	-0.78	-0.77	-0.3	-0.66	-0.78	-0.8	-0.69	-0.34	-0.85	-0.73	1.0	-0.77	0.13	0.33	-0.47

Click cells to compare fundamentals

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Common Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Common Stock	737.3 M	375.9 M
Common Stock Shares Outstanding	37.4 M	24.3 M
Common Stock Total Equity	587.1 M	389 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TransMedics Common Stock from 2010 to 2025

Latest TransMedics' Common Stock Growth Pattern

TransMedics Common Stock Regression Statistics

TransMedics Common Stock History

Other Fundumenentals of TransMedics Group

TransMedics Common Stock component correlations

About TransMedics Financial Statements

Also Currently Popular

Additional Tools for TransMedics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY